1626 studies found for:    Open Studies | "Liver Diseases"
Show Display Options
Rank Status Study
21 Recruiting Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Omegaven
22 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:
23 Unknown  Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Fish Oil Supplementation;   Drug: Placebo Supplementation
24 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
25 Unknown  Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Procedure: Phlebotomy
26 Recruiting Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Behavioral: Experimental: Low-fructose, reduced carbohydrate diet;   Behavioral: General Healthy Diet
27 Unknown  Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Lovaza;   Drug: placebo control
28 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
29 Not yet recruiting Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease in Diabetic Patients
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD).;   Nonalcoholic Steatohepatitis.;   Diabetes.
Interventions: Procedure: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).;   Other: Low carbohydrate diet
30 Recruiting Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Drug: Sillymarin
31 Unknown  Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Dietary Supplement: High oral Fructose challenge (150g per day for 28 days)
32 Not yet recruiting Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: atorvastatin;   Behavioral: lifestyle counseling
33 Recruiting The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Drug: Acetaminophen
34 Not yet recruiting The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Dietary Supplement: β- glucan;   Dietary Supplement: Maltodextrin
35 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platlet count);   Drug: avatrombopag (higer baseline platelet count);   Drug: placebo (higher baseline platelet count)
36 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platlet count);   Drug: avatrombopag (higer baseline platelet count);   Drug: placebo (higher baseline platelet count)
37 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
Condition: Thrombocytopenia Associated With Chronic Liver Disease
Interventions: Drug: avatrombopag;   Drug: Placebo
38 Recruiting A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
Conditions: Alcoholism,;   Alcoholic Liver Disease
Intervention: Drug: Metadoxine
39 Unknown  Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease
Condition: Alcoholic Liver Disease
Intervention: Drug: LACTOWELL
40 Recruiting Baclofen in the Treatment of Alcoholic Liver Disease
Conditions: Alcoholic Liver Disease;   Alcohol Dependence
Interventions: Drug: Baclofen 30mg/day;   Drug: Baclofen 75mg/day;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years